Effects of increasing cannabis potency on adolescent health

Jack Wilson, Tom P Freeman, Clare J Mackie

Research output: Contribution to journalReview article

1 Citation (Scopus)
5 Downloads (Pure)

Abstract

Cannabis is the most prevalent illicit drug used by adolescents worldwide. Over the past 40 years, changes in cannabis potency through rising concentrations of Δ-9-tetrahydrocannabiol (THC), decreases in cannabidiol, or both, have occurred. Epidemiological and experimental evidence demonstrates that cannabis with high THC concentrations and negligible cannabidiol concentrations is associated with an increased risk of psychotic outcomes, an effect on spatial working memory and prose recall, and increased reports of the severity of cannabis dependence. However, many studies have failed to address cannabis use in adolescence, the peak age at which individuals typically try cannabis and probably the most vulnerable age to experience its harmful effects. In this Review, we highlight the influence that changing cannabis products have on adolescent health and the implications they carry for policy and prevention measures as legal cannabis markets continue to emerge worldwide.

Original languageEnglish
Pages (from-to)121-128
Number of pages8
JournalThe Lancet Child & Adolescent Health
Volume3
Issue number2
Early online date17 Dec 2018
DOIs
Publication statusPublished - 1 Feb 2019

Cite this

Effects of increasing cannabis potency on adolescent health. / Wilson, Jack; Freeman, Tom P; Mackie, Clare J.

In: The Lancet Child & Adolescent Health, Vol. 3, No. 2, 01.02.2019, p. 121-128.

Research output: Contribution to journalReview article

Wilson, Jack ; Freeman, Tom P ; Mackie, Clare J. / Effects of increasing cannabis potency on adolescent health. In: The Lancet Child & Adolescent Health. 2019 ; Vol. 3, No. 2. pp. 121-128.
@article{e1a4ba8d6e4a4c2fb9fa1c41d81ed145,
title = "Effects of increasing cannabis potency on adolescent health",
abstract = "Cannabis is the most prevalent illicit drug used by adolescents worldwide. Over the past 40 years, changes in cannabis potency through rising concentrations of Δ-9-tetrahydrocannabiol (THC), decreases in cannabidiol, or both, have occurred. Epidemiological and experimental evidence demonstrates that cannabis with high THC concentrations and negligible cannabidiol concentrations is associated with an increased risk of psychotic outcomes, an effect on spatial working memory and prose recall, and increased reports of the severity of cannabis dependence. However, many studies have failed to address cannabis use in adolescence, the peak age at which individuals typically try cannabis and probably the most vulnerable age to experience its harmful effects. In this Review, we highlight the influence that changing cannabis products have on adolescent health and the implications they carry for policy and prevention measures as legal cannabis markets continue to emerge worldwide.",
author = "Jack Wilson and Freeman, {Tom P} and Mackie, {Clare J}",
note = "Copyright {\circledC} 2018 Elsevier Ltd. All rights reserved.",
year = "2019",
month = "2",
day = "1",
doi = "10.1016/S2352-4642(18)30342-0",
language = "English",
volume = "3",
pages = "121--128",
journal = "The Lancet Child & Adolescent Health",
issn = "2352-4650",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Effects of increasing cannabis potency on adolescent health

AU - Wilson, Jack

AU - Freeman, Tom P

AU - Mackie, Clare J

N1 - Copyright © 2018 Elsevier Ltd. All rights reserved.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Cannabis is the most prevalent illicit drug used by adolescents worldwide. Over the past 40 years, changes in cannabis potency through rising concentrations of Δ-9-tetrahydrocannabiol (THC), decreases in cannabidiol, or both, have occurred. Epidemiological and experimental evidence demonstrates that cannabis with high THC concentrations and negligible cannabidiol concentrations is associated with an increased risk of psychotic outcomes, an effect on spatial working memory and prose recall, and increased reports of the severity of cannabis dependence. However, many studies have failed to address cannabis use in adolescence, the peak age at which individuals typically try cannabis and probably the most vulnerable age to experience its harmful effects. In this Review, we highlight the influence that changing cannabis products have on adolescent health and the implications they carry for policy and prevention measures as legal cannabis markets continue to emerge worldwide.

AB - Cannabis is the most prevalent illicit drug used by adolescents worldwide. Over the past 40 years, changes in cannabis potency through rising concentrations of Δ-9-tetrahydrocannabiol (THC), decreases in cannabidiol, or both, have occurred. Epidemiological and experimental evidence demonstrates that cannabis with high THC concentrations and negligible cannabidiol concentrations is associated with an increased risk of psychotic outcomes, an effect on spatial working memory and prose recall, and increased reports of the severity of cannabis dependence. However, many studies have failed to address cannabis use in adolescence, the peak age at which individuals typically try cannabis and probably the most vulnerable age to experience its harmful effects. In this Review, we highlight the influence that changing cannabis products have on adolescent health and the implications they carry for policy and prevention measures as legal cannabis markets continue to emerge worldwide.

U2 - 10.1016/S2352-4642(18)30342-0

DO - 10.1016/S2352-4642(18)30342-0

M3 - Review article

VL - 3

SP - 121

EP - 128

JO - The Lancet Child & Adolescent Health

JF - The Lancet Child & Adolescent Health

SN - 2352-4650

IS - 2

ER -